OSAvit-D SIGNED
POINT OF CARE DEVICE FOR VITAMIN D DEFICIENCY MONITORING
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0OSAvit-D project word cloud
Explore the words cloud of the OSAvit-D project. It provides you a very rough idea of what is the project "OSAvit-D" about.
Project "OSAvit-D" data sheet
The following table provides information about the project.
| Coordinator |
OSASEN SENSORES S.L.
Organization address contact info |
| Coordinator Country | Spain [ES] |
| Total cost | 100˙687 € |
| EC max contribution | 100˙687 € (100%) |
| Programme |
1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs) |
| Code Call | H2020-INNOSUP-2019-02 |
| Funding Scheme | CSA |
| Starting year | 2019 |
| Duration (year-month-day) | from 2019-10-15 to 2020-10-14 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | OSASEN SENSORES S.L. | ES (DERIO) | coordinator | 100˙687.00 |
Map
Project objective
OSASEN is a young technological SME focused on the development of novel biosensors for healthcare (Point of Care-PoC devices), addressing priority needs in healthcare diagnostics and/or therapies monitoring for the benefit of patients, providing affordable systems with unique features that meet specific well identified requirements in healthcare. OSASEN has recently identified a healthcare need in relation with prevention, treatment and monitoring of Vitamin D (VitD) deficiency. VitD (1,25-DihydroxyvitaminD) is considered a multipurpose steroid hormone that in human plays an essential role in multiple aspects, being its primary role to participate in the regulation of metabolism of calcium and phosphorous. VitD deficiency is evident throughout the European population at a prevalence of 13% (FP7-613977-ODIN project), a rate that is a matter of concern. People over 50 have an increased risk of vitamin D deficiency with consequent bone loss risk leading to osteoporosis and fractures. Emerging evidence has shown that VitD administration improves muscle performance and reduces falls in VitD deficient older adults. Other populations of higher risk for VitD deficiency are children, pregnant and lactating women and patients with digestive disorders, among others. VitD deficiency is also associated with increased risk of cancer, cardiovascular disease, infections, and autoimmune diseases. For example, several studies have shown that VitD levels are lower in Multiple Sclerosis patients, and monitoring and VitD supplementation to them is highly recommended. In this context, OSASEN has identified the opportunity to develop a novel PoC device for the quantification of VitD in blood or urine based on lateral flow (LF) immunoassay, combined with electrochemical detection on screen printed electrodes (SPEs). For doing so, it is necessary to incorporate an expert in LF immunoassays and antibody selection, conjugation, handling & stabilization to OSASEN’s team.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OSAVIT-D" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OSAVIT-D" are provided by the European Opendata Portal: CORDIS opendata.